Feng, Y., Spezia, M., Huang, S., Yuan, C., Zeng, Z., Zhang, L., ... & Ren, G. (2018). Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Genes & diseases, 5(2), 77-106.‏

Ward, C., Meehan, J., Mullen, P., Supuran, C., Dixon, J. M., Thomas, J. S., ... & Langdon, S. P. (2015). Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models. Oncotarget, 6(28), 24856.‏

Alwan, N. A. (2016). Breast cancer among Iraqi women: Preliminary findings from a regional comparative Breast Cancer Research Project. Journal of global oncology, 2(5), 255.‏

Tremblay, D., Latreille, J., Bilodeau, K., Samson, A., Roy, L., L’Italien, M. F., & Mimeault, C. (2016). Improving the transition from oncology to primary care teams: a case for shared leadership. Journal of oncology practice, 12(11), 1012-1019.‏

Chabner, B. A., & Roberts Jr, T. G. (2005). Chemotherapy and the war on cancer. Nature Reviews Cancer, 5(1), 65-72.‏

Weaver, B. A. (2014). How Taxol/paclitaxel kills cancer cells. Molecular biology of the cell, 25(18), 2677-2681.‏

Xiao, Q., Zhou, Y., & Lauschke, V. M. (2020). Impact of variants in ATP-binding cassette transporters on breast cancer treatment. Pharmacogenomics, 21(18), 1299-1310.‏

Mielke, S., Mross, K., Gerds, T. A., Schmidt, A., Wäsch, R., Berger, D. P., ... & Behringer, D. (2003). Comparative neurotoxicity of weekly non-break paclitaxel infusions over 1 versus 3 h. Anti-cancer drugs, 14(10), 785-792.‏

Nelson, H. D., Zakher, B., Cantor, A., Fu, R., Griffin, J., O'Meara, E. S., ... & Miglioretti, D. L. (2012). Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Annals of internal medicine, 156(9), 635-648.‏

Miranda-Galvis, M., Loveless, R., Kowalski, L. P., & Teng, Y. (2021). Impacts of environmental factors on head and neck cancer pathogenesis and progression. Cells, 10(2), 389.‏

Greenup, R. A., Rushing, C., Fish, L., Campbell, B. M., Tolnitch, L., Hyslop, T., ... & Hwang, E. S. (2019). Financial costs and burden related to decisions for breast cancer surgery. Journal of oncology practice, 15(8), e666-e676.‏

Berhili, S., Kadiri, S., Bouziane, A., Aissa, A., Marnouche, E., Ogandaga, E., ... & Benjaafar, N. (2017). Associated factors with psychological distress in Moroccan breast cancer patients: a cross-sectional study. The breast, 31, 26-33.‏

Helms, E., Onate, M. K., & Sherman, M. H. (2020). Fibroblast Heterogeneity in the Pancreatic Tumor MicroenvironmentFibroblast Heterogeneity in Pancreatic Cancer. Cancer discovery, 10(5), 648-656.‏

Kryukov, A. V., Sychev, D. A., Andreev, D. A., Ryzhikova, K. A., Grishina, E. A., Ryabova, A. V., ... & Bochkov, P. O. (2018). Influence of ABCB1 and CYP3A5 gene polymorphisms on pharmacokinetics of apixaban in patients with atrial fibrillation and acute stroke. Pharmacogenomics and personalized medicine, 43-49.‏

Barliana, M. I., Kusuma, A. S. W., Insani, W. N., Alfian, S. D., Diantini, A., Mutakin, M., ... & Abdulah, R. (2021). Genetic variation of ABCB1 (rs1128503, rs1045642) and CYP2E1 rs3813867 with the duration of tuberculosis therapy: a pilot study among tuberculosis patients in Indonesia. BMC Research Notes, 14(1), 1-7.‏